|
|
|
Volumn 17, Issue 5 Suppl 5, 2003, Pages 46-51
|
|
Combined inhibition of topoisomerases: a phase I. Study of irinotecan and epirubicin.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CAMPTOTHECIN;
DNA TOPOISOMERASE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
EPIRUBICIN;
IRINOTECAN;
ADULT;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG SCREENING;
ENZYMOLOGY;
FEMALE;
HUMAN;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
REVIEW;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
DNA TOPOISOMERASES;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
EPIRUBICIN;
FEMALE;
HUMANS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASMS;
|
|
EID: 0141783772
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (30)
|
